Back to Journals » Drug Design, Development and Therapy » Volume 15

Profile of Enfortumab Vedotin in the Treatment of Urothelial Carcinoma: The Evidence to Date

Total article views   HTML views PDF downloads Totals
7,411 Dovepress* 5,117+ 571 5,688
PubMed Central* 2,294 371 2,665
Totals 7,411 942 8,353
*Since 11 February 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar